📖
Is HER2-Low Breast Cancer a Distinct Prognostic Entity? Real-World Survival Outcomes from a Cohort in Colombia.
Manrique-Hernández EF, Licht-Ardila M, Torres Rosas JD, Rincón Pallares JA, Villabona Díaz MS, Aldana Galvis LK, Hoyos K, Hurtado-Ortiz A, Calderón Cortés C, Gómez-Abreo D

Is HER2-Low Breast Cancer a Distinct Prognostic Entity? Real-World Survival Outcomes from a Cohort in Colombia.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Cancers (Basel).

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Is HER2-Low Breast Cancer a Distinct Prognostic Entity? Real-World Survival Outcomes from a Cohort in Colombia.
Author / Organization Manrique-Hernández EF, Licht-Ardila M, Torres Rosas JD, Rincón Pallares JA, Villabona Díaz MS, Aldana Galvis LK, Hoyos K, Hurtado-Ortiz A, Calderón Cortés C, Gómez-Abreo D
Subject & Discipline Cancers (Basel)
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-259268
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »